Quarterly report pursuant to Section 13 or 15(d)

Revenue Disaggregation

v3.24.0.1
Revenue Disaggregation
 9 Months Ended
Dec. 31, 2023
Revenue from Contract with Customer [Abstract]  
Revenue Disaggregation

 

Note 10. Revenue Disaggregation

 

The Company generates revenues from products which are sold into the human and animal healthcare markets and to multiple geographic regions.

 

The following table presents the Company’s disaggregated revenues by revenue source:

                         
(In thousands)   Three Months Ended December 31,     Nine Months Ended December 31,  
    2023     2022     2023     2022  
Human Care   $ 2,461     $ 2,435     $ 7,286     $ 7,050  
Animal Care     621       434       1,688       1,957  
Service and Royalty     56       75       322       1,251  
    $ 3,138     $ 2,944     $ 9,296     $ 10,258  

 

The following table shows the Company’s revenues by geographic region:

                         
    Three Months Ended December 31,     Nine Months Ended December 31,  
(In thousands)   2023     2022     2023     2022  
United States   $ 868     $ 761     $ 2,214     $ 2,603  
Europe     1,217       1,104       3,488       3,117  
Asia     522       514       1,730       1,952  
Latin America     368       384       1,165       1,827  
Rest of the World     163       181       699       759  
Total   $ 3,138     $ 2,944     $ 9,296     $ 10,258